The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.
Adult patient below 80 yo
Patients with MASLD/MASH recruited in interventional trials requiring MRI PDFF +/- MRE per interventional protocol, OR
Patients with MASLD/MASH recruited in prospective cohorts requiring MRI PDFF +/- MRE per interventional protocol, OR
Patients referred to MRI-PDFF or MRE.
Patient in their minority (less than 18 yo) or older than 80 yo,
Patient with active implants,
Patient presenting with a wound where the Hepatoscope exam shall be performed (abdominal right upper quadrant)
Patient with a history of decompensated cirrhosis,